Tango Therapeutics (TNGX) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
Tango Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 5 sold $12.5M of TNGX stock on the open market.
Get emailed when insiders cluster-buy stocks like TNGX
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
TNGX insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | $661K | 2 |
| Q3 2026 | — | 0 | $2.3M | 8 |
| Q2 2026 | — | 0 | $2.7M | 6 |
| Q1 2026 | — | 0 | $2.0M | 9 |
| Q4 2025 | — | 0 | $4.8M | 1 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 Tango Therapeutics, Inc. insiders reported open-market purchases totaling $0, while 5 insiders reported sales totaling $12.5M. 19 of 26 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Oct 5SEC | Adam CrystalPresident | Sell Plan | 26,400116,343 held (−18%) | $24.45 | $646K | -2.6% | — |
| Oct 5SEC | Adam CrystalPresident | Sell Plan | 600115,743 held (−1%) | $25.32 | $15K | -6.0% | — |
| Sep 24SEC | Jessica NewcombPrincipal Accounting Officer | Sell Plan | 5,10061,521 held (−8%) | $23.97 | $122K | -0.7% | — |
| Sep 24SEC | Jessica NewcombPrincipal Accounting Officer | Sell Plan | 2,40059,121 held (−4%) | $25.17 | $60K | -5.4% | — |
| Sep 24SEC | Jessica NewcombPrincipal Accounting Officer | Sell Plan | 70066,621 held (−1%) | $22.80 | $16K | +4.4% | — |
| Sep 3SEC | Adam CrystalPresident | Sell Plan | 27,000115,743 held (−19%) | $22.37 | $604K | +6.4% | — |
| Aug 5SEC | Adam CrystalPresident | Sell Plan | 21,733115,743 held (−16%) | $27.35 | $594K | -12.9% | — |
| Aug 5SEC | Adam CrystalPresident | Sell Plan | 5,267137,476 held (−4%) | $26.79 | $141K | -11.1% | — |
| Jul 2SEC | Adam CrystalPresident | Sell Plan | 19,629123,114 held (−14%) | $29.34 | $576K | -18.8% | — |
| Jul 2SEC | Adam CrystalPresident | Sell Plan | 7,371115,743 held (−6%) | $30.25 | $223K | -21.3% | — |
| Jun 3SEC | Adam CrystalPresident | Sell Plan | 20,860115,743 held (−15%) | $23.06 | $481K | +3.3% | — |
| Jun 3SEC | Adam CrystalPresident | Sell Plan | 6,140136,603 held (−4%) | $22.25 | $137K | +7.0% | — |
| May 5SEC | Adam CrystalPresident | Sell Plan | 25,900116,843 held (−18%) | $21.19 | $549K | +12.4% | — |
| May 5SEC | Adam CrystalPresident | Sell Plan | 1,100115,743 held (−1%) | $22.00 | $24K | +8.2% | — |
| Apr 16SEC | Adam CrystalPresident | Sell Plan | 38,460112,622 held (−25%) | $25.00 | $962K | -4.8% | — |
| Apr 2SEC | Adam CrystalPresident | Sell Plan | 27,000112,622 held (−19%) | $21.20 | $572K | +12.3% | — |
| Mar 27SEC | Adam CrystalPresident | Sell Plan | 12,000112,622 held (−10%) | $20.11 | $241K | +18.4% | — |
| Mar 9SEC | Adam CrystalPresident | Sell Plan | 20,251112,622 held (−15%) | $15.00 | $304K | +58.7% | — |
| Feb 27SEC | Adam CrystalPresident | Sell Plan | 54,345132,873 held (−29%) | $12.77 | $694K | +86.5% | — |
| Feb 4SEC | Barbara WeberChair | Sell | 30,1861,629,587 held (−2%) | $12.26 | $370K | +94.2% | — |
| Feb 4SEC | Adam CrystalPresident | Sell | 18,251187,419 held (−9%) | $12.26 | $224K | +94.2% | — |
| Feb 4SEC | Daniella BeckmanCFO | Sell | 10,204184,410 held (−5%) | $12.26 | $125K | +94.2% | — |
| Feb 4SEC | Barbara WeberChair | Sell | 3331,629,254 held (−0%) | $12.90 | $4K | +84.6% | — |
| Feb 4SEC | Adam CrystalPresident | Sell | 201187,218 held (−0%) | $12.90 | $3K | +84.6% | — |
| Feb 4SEC | Daniella BeckmanCFO | Sell | 113184,297 held (−0%) | $12.90 | $1K | +84.6% | — |
| Oct 27SEC | Trv Gp Iv, Llc10% Owner | Sell | 477,40113,386,574 held (−3%) | $10.15 | $4.8M | +134.6% | — |
Insiders at Tango Therapeutics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Adam CrystalPresident | — | $7.0M | Oct 5, 2026 | — |
| Trv Gp Iv, Llc10% Owner | — | $4.8M | Oct 27, 2025 | — |
| Barbara WeberChair | — | $374K | Feb 4, 2026 | — |
| Jessica NewcombPrincipal Accounting Officer | — | $199K | Sep 24, 2026 | — |
| Daniella BeckmanCFO | — | $127K | Feb 4, 2026 | — |
TNGX stock: common questions
Are Tango Therapeutics, Inc. insiders buying TNGX stock?
In the past 12 months, 0 insiders reported open-market purchases of TNGX worth $0.
Are Tango Therapeutics, Inc. insiders selling TNGX stock?
5 insiders reported sales worth $12.5M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is TNGX's 52-week range?
Over the past year TNGX has traded between $7.14 and $32.90. It last closed at $23.81 on Oct 9, 2026.